Physician profile
Asha B Bhalwal
NPI 1174887285
$151,230.04
in general payments reported to CMS, 2019-2025
33 companies · $65K in 2025
The $65K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,089 · 2020: $1,468 · 2021: $670 · 2022: $24K · 2023: $32K · 2024: $28K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $63K · Travel and Lodging: $25K · Education: $16K · Consulting Fee: $16K · Food and Beverage: $4,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $62,500.00 |
| Travel and Lodging | $24,565.32 |
| Education | $16,300.00 |
| Consulting Fee | $15,725.00 |
| Food and Beverage | $4,851.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $87,916.34 | 2020-2025 | Gelpoint V-Path |
| Intuitive Surgical, INC. | $25,717.81 | 2022-2025 | |
| Distalmotion US | $24,678.93 | 2024-2025 | Dexter L6 Robot |
| Gynesonics, INC. | $3,395.13 | 2021-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Baxter Healthcare | $3,293.99 | 2020-2025 | Tisseel, Perclot |
| Medtronic, INC. | $1,315.49 | 2022-2025 | Hysterolux Fluid Management System Control Unit, V-Loc 180, Ligasure |
| Covidien LP | $1,171.81 | 2019-2020 | |
| Conmed Corporation | $800.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $387.34 | 2021-2023 | Exparel |
| Davol INC. | $321.72 | 2024-2025 | Arista, Arista Ah Flexitip |
| Becton, Dickinson and Company | $213.75 | 2025 | |
| Hologic Sales and Service, LLC | $208.15 | 2020-2025 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Meditrina | $184.14 | 2023 | |
| Abbvie INC. | $180.41 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Olympus America INC. | $168.20 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allotrope Medical, INC | $159.53 | 2022 | |
| Sumitomo Pharma America, INC. | $148.43 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $122.01 | 2021-2022 | |
| Ethicon US, LLC | $117.51 | 2021-2023 | Enseal, Stratafix, Evarrest |
| Boston Scientific Corporation | $114.02 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.04 | 2021-2022 | |
| Coopersurgical, INC. | $88.82 | 2019-2025 | Ally II Ups |
| Aspira Women'S Health INC | $85.10 | 2020-2024 | Ova1 |
| Acessa Health INC. | $84.58 | 2019 | |
| Smith+Nephew, INC. | $55.18 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $53.27 | 2022 | |
| Exeltis, USA INC. | $39.51 | 2024-2025 | Slynd |
| Evofem Biosciences, INC. | $37.66 | 2022-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $22.17 | 2022 | |
| Astellas Pharma US INC | $15.80 | 2020 | |
| Convatec INC. | $14.07 | 2022 | |
| Agile Therapeutics, INC. | $13.70 | 2023 | Twirla |
| Pfizer INC. | $13.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Bhalwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.